Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

1.

Pancreaticoduodenetomy combined with hepatic artery resection following preoperative hepatic arterial embolization.

Yoshidome H, Shimizu H, Ohtsuka M, Yoshitomi H, Kato A, Furukawa K, Miyazaki M.

J Hepatobiliary Pancreat Sci. 2014 Dec;21(12):850-5. doi: 10.1002/jhbp.192.

PMID:
25410529
2.

Preoperative immunonutrition decreases postoperative complications by modulating prostaglandin E2 production and T-cell differentiation in patients undergoing pancreatoduodenectomy.

Aida T, Furukawa K, Suzuki D, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Miyazaki M.

Surgery. 2014 Jan;155(1):124-33. doi: 10.1016/j.surg.2013.05.040. Epub 2013 Oct 25.

PMID:
24589090
3.

Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of left trisectionectomy.

Hosokawa I, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Miyazaki M.

Ann Surg. 2014 Jun;259(6):1178-85. doi: 10.1097/SLA.0000000000000584.

PMID:
24509210
4.

Optimal cut-off value for the number of colorectal liver metastases: a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Beppu T, Sakamoto Y, Hasegawa K, Honda G, Tanaka K, Kotera Y, Nitta H, Yoshidome H, Hatano E, Ueno M, Takamura H, Baba H, Kosuge T, Kokudo N, Takahashi K, Endo I, Wakabayashi G, Miyazaki M, Uemoto S, Ohta T, Kikuchi K, Takayama T, Yamaue H, Yamamoto M, Takada T.

J Hepatobiliary Pancreat Sci. 2014 Mar;21(3):169-75. doi: 10.1002/jhbp.58. Epub 2013 Dec 5.

PMID:
24307562
5.

Cytoskeleton-associated protein 2 is a potential predictive marker for risk of early and extensive recurrence of hepatocellular carcinoma after operative resection.

Hayashi T, Ohtsuka M, Okamura D, Seki N, Kimura F, Shimizu H, Yoshidome H, Kato A, Yoshitomi H, Furukawa K, Miyazaki M.

Surgery. 2014 Jan;155(1):114-23. doi: 10.1016/j.surg.2013.06.009. Epub 2013 Nov 12.

PMID:
24238125
6.

Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?

Miyazaki M, Yoshitomi H, Shimizu H, Ohtsuka M, Yoshidome H, Furukawa K, Takayasiki T, Kuboki S, Okamura D, Suzuki D, Nakajima M.

Surgery. 2014 Jan;155(1):58-66. doi: 10.1016/j.surg.2013.06.050. Epub 2013 Nov 12.

PMID:
24238124
7.

Protective effects of simultaneous splenectomy on small-for-size liver graft injury in rat liver transplantation.

Yoichi T, Takayashiki T, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Kuboki S, Okamura D, Suzuki D, Nakajima M, Miyazaki M.

Transpl Int. 2014 Jan;27(1):106-13. doi: 10.1111/tri.12223. Epub 2013 Nov 14.

PMID:
24164377
8.

Kinetics and protective role of autophagy in a mouse cecal ligation and puncture-induced sepsis.

Takahashi W, Watanabe E, Fujimura L, Watanabe-Takano H, Yoshidome H, Swanson PE, Tokuhisa T, Oda S, Hatano M.

Crit Care. 2013 Jul 24;17(4):R160. doi: 10.1186/cc12839.

9.

Left hepatic trisectionectomy for hepatolithiasis with occluded left and right anterior branches of the portal vein: report of a case.

Hosokawa I, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S, Okamura D, Suzuki D, Nakajima M, Miyazaki M.

Surg Today. 2014 Aug;44(8):1556-60. doi: 10.1007/s00595-013-0598-1. Epub 2013 May 21.

PMID:
23689948
10.

[Revision of the training curriculum of Japan Society of Gastroenterology: biliary tract and pancreas].

Motoo Y, Hirooka Y, Shimizu K, Isayama H, Yoshidome H.

Nihon Shokakibyo Gakkai Zasshi. 2013 May;110(5):820-4. Japanese. No abstract available.

PMID:
23648537
11.

[Treatment strategy for multiple colorectal liver metastases: role for two-stage hepatectomy].

Yoshidome H, Miyazaki M.

Nihon Geka Gakkai Zasshi. 2013 Jan;114(1):39-43. Japanese.

PMID:
23457945
12.

Chylous ascites after hepatopancreatobiliary surgery.

Kuboki S, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Miyazaki M.

Br J Surg. 2013 Mar;100(4):522-7. doi: 10.1002/bjs.9013. Epub 2013 Jan 3.

PMID:
23288577
13.

[A case of pancreaticoduodenectomy for duodenal carcinoma with a replaced common hepatic artery running through the pancreatic parenchyma].

Hosokawa I, Shimizu H, Nakajima M, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Kuboki S, Suzuki D, Miyazaki M.

Gan To Kagaku Ryoho. 2012 Nov;39(12):1963-5. Japanese.

PMID:
23267944
14.

Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study.

Kato A, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Kimura F, Miyazaki M.

Ann Surg Oncol. 2013 Jan;20(1):318-24. doi: 10.1245/s10434-012-2312-8. Epub 2012 Nov 13.

PMID:
23149849
15.

[Surgical outcome of biliary tract cancer with neoadjuvant chemotherapy].

Kato A, Shimizu H, Yoshidome H, Otsuka M, Furukawa K, Yoshitomi H, Takeuchi D, Takayashiki T, Kuboki S, Suzuki D, Nakajima M, Miyazaki M.

Gan To Kagaku Ryoho. 2012 Oct;39(10):1486-9. Japanese. No abstract available.

PMID:
23133873
16.

Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells.

Kagawa S, Takano S, Yoshitomi H, Kimura F, Satoh M, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Furukawa K, Matsushita K, Nomura F, Miyazaki M.

J Surg Res. 2012 Dec;178(2):758-67. doi: 10.1016/j.jss.2012.05.065. Epub 2012 Jun 12.

PMID:
22726648
17.

Intrahepatic cholangiojejunostomy (Longmire procedure) for recurrent bilioenteric anastomotic stricture with hepatolithiasis.

Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Furukawa K, Mitsuhashi N, Takeuchi D, Takayashiki T, Suda K, Miyazaki M.

Hepatogastroenterology. 2012 Jun;59(116):1023-5. doi: 10.5754/hge08093.

PMID:
22580652
18.

Hepatic S4a + S5 and bile duct resection for gallbladder carcinoma.

Miyazaki M, Shimizu H, Ohtsuka M, Yoshidome H, Kato A, Yoshitomi H, Furukawa K, Kimura F.

J Hepatobiliary Pancreat Sci. 2012 May;19(3):225-9. doi: 10.1007/s00534-011-0500-8.

PMID:
22374509
19.

Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma.

Miura S, Mitsuhashi N, Shimizu H, Kimura F, Yoshidome H, Otsuka M, Kato A, Shida T, Okamura D, Miyazaki M.

BMC Cancer. 2012 Feb 6;12:56. doi: 10.1186/1471-2407-12-56.

20.

Usefulness of preoperative partial splenic embolization in hepatocellular carcinoma and hypersplenic thrombocytopenia.

Yoshidome H, Kimura F, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Suda K, Takano S, Miyazaki M.

Hepatogastroenterology. 2011 Nov-Dec;58(112):2062-6. doi: 10.5754/hge09590.

PMID:
22234078
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk